Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Comment by archeo753on Jun 20, 2024 4:25pm
84 Views
Post# 36098765

RE:RE:RE:Horrific value destruction

RE:RE:RE:Horrific value destructionPremerger CZO shares now worth $0.1425.  Is that an all time low?  Zero reson for any new shareholders to purchase AEZS shares so dramatic decline on very low volume.  A new name and a complete reset is deperately needed. 

Ciao wrote:
lscfa wrote: Sell off must be CZO shareholders selling their newly acquired AEZS shares after merger.


Could be the exisitng AEZS shareholders as well who essentially got free shares to up their holdings by 50%

"Additionally, as part of the Transaction, Aeterna will issue to its shareholders immediately prior to the closing of the Transaction, 0.47698 of a share purchase warrant (“Transaction Warrant”) for each Aeterna common share held as of such date. Each Transaction Warrant will have a term of three years and each whole Transaction Warrant will be exercisable to purchase one common share of Aeterna at a nominal exercise price of US.01."

As I noted, it was a weasel way to have more dilution while giving the illusion of a better share exchange ratio to CZO shareholders.



<< Previous
Bullboard Posts
Next >>